EGF and lung carcinoma: Contrary to these studies, other groups reported that IL-17RD overexpression potentiates epidermal growth factor (EGF)-stimulated ERK1/2 activation in 293 cells (23) and steady-state ERK1/2 phosphorylation in mesenchymal lung cancer cells (24).